{"schema_version":"secwatch.filing_event.v1","accession":"0001534969-22-000048","form_type":"8-K","ticker":"SERA","cik":"0001534969","company_name":"SERA PROGNOSTICS, INC.","filed_at":"2022-04-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.115277+00:00","generated_at":"2026-06-26T07:56:31.679081+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sera Prognostics appoints Dr. Jane F. Barlow to Board of Directors","bullets":["Dr. Jane F. Barlow appointed as Class I Director effective April 11, 2022; term expires at 2022 annual meeting.","Dr. Barlow brings experience from CVS Health, Medco, and boards of ContraFect, Viracta, Point Health.","Granted non-qualified stock option with $240,000 grant date fair value, vesting monthly over 36 months.","Entitled to annual cash retainer of $35,000 for non-employee director service, prorated.","Company entered into standard indemnification agreement with Dr. Barlow."],"urls":{"canonical":"https://secwatch.observer/filing/0001534969-22-000048","json":"https://secwatch.observer/filing/0001534969-22-000048.json","markdown":"https://secwatch.observer/filing/0001534969-22-000048.md","text":"https://secwatch.observer/filing/0001534969-22-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534969/000153496922000048/0001534969-22-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534969/000153496922000048/sera-20220411.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T07:56:31.679081+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9bd05e76e0","claim":"Jane F. Barlow was appointed as Class I Director at SERA PROGNOSTICS, INC..","evidence_excerpt":"On April 11, 2022, the Board of Directors (the “Board”) of Sera Prognostics, Inc. (the “Company”) appointed Jane F. Barlow, M.D., MPH, MBA, effective April 11, 2022 (the “Effective Date”), as a director to the Board to serve as a Class I Director with a term expiring at the Company’s 2022 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534969/000153496922000048/0001534969-22-000048-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}